Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 4/20 | 0.71 |
| ▸ | HPGD | P15428 | 4/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.71 |
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.71 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.71 |
| ▸ | HTT | P42858 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.71 |
| ▸ | USP2 | O75604 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.71 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.71 |
| ▸ | IDO1 | P14902 | 1/20 | 0.71 |
| ▸ | CASP1 | P29466 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31515787 | 1.00 | HIF1A (0.71) | HIF1AHPGDALOX15CYP3A4MEN1 | |
| Heptane SCHEMBL11365624 | 0.87 | HIF1A (0.55) | HIF1AHPGDALOX15CYP3A4MEN1 | |
| Dichlorophen SCHEMBL18052 | 0.83 | CYP3A4 (1.00) | HIF1AHPGDALOX15CYP3A4MEN1 | |
| Dichlorophen SCHEMBL29524636 | 0.83 | CYP3A4 (1.00) | HIF1AHPGDALOX15CYP3A4MEN1 | |
| Dichlorophen SCHEMBL9109126 | 0.83 | CYP3A4 (1.00) | HIF1AHPGDALOX15CYP3A4MEN1 | |
| Dichlorophen SCHEMBL29349447 | 0.83 | CYP3A4 (1.00) | HIF1AHPGDALOX15CYP3A4MEN1 | |
| Dichlorophen SCHEMBL18694833 | 0.82 | CYP3A4 (0.71) | HIF1AHPGDALOX15CYP3A4MEN1 | |
| SCHEMBL2982937 | 0.82 | ALOX15 (0.65) | HIF1AHPGDALOX15CYP3A4MEN1 | |
| Dichlorophen SCHEMBL2471883 | 0.81 | CYP3A4 (0.95) | HIF1AHPGDALOX15CYP3A4MEN1 | |
| Dichlorophen SCHEMBL735904 | 0.81 | CYP3A4 (0.95) | HIF1AHPGDALOX15CYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113717371-B | Preparation method of low-viscosity reactive flame-retardant polyether polyol, reactive flame-retardant heat-conducting polyurethane electronic pouring sealant and preparation method thereof | 山东一诺威新材料有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-113717371-A | Preparation method of low-viscosity reactive flame-retardant polyether polyol, reactive flame-retardant heat-conducting polyurethane electronic pouring sealant and preparation method thereof | 山东一诺威新材料有限公司 | 2021-11-30 | — | — | CN | claimed |
| US-20240209016-A1 | FLUORESCENT NUCLEOSIDE PHOSPHATES | STEALTH LABELS BIOTECH AB (SE) | 2024-06-27 | — | — | US | disclosed |
| EP-4323373-A1 | FLUORESCENT NUCLEOSIDE PHOSPHATES | STEALTH LABELS BIOTECH AB (SE) | 2024-02-21 | — | — | EP | disclosed |
| CN-113717371-B | Preparation method of low-viscosity reactive flame-retardant polyether polyol, reactive flame-retardant heat-conducting polyurethane electronic pouring sealant and preparation method thereof | 山东一诺威新材料有限公司 | 2023-11-10 | — | — | CN | disclosed |
| US-11708364-B2 | Azaindole derivatives and their use as ERK kinase inhibitors | AGV DISCOVERY (FR) | 2023-07-25 | — | — | US | disclosed |
| US-11708364-B2 | Azaindole derivatives and their use as ERK kinase inhibitors | AGV DISCOVERY (FR) | 2023-07-25 | — | — | US | disclosed |
| US-11708364-B2 | Azaindole derivatives and their use as ERK kinase inhibitors | AGV DISCOVERY (FR) | 2023-07-25 | — | — | US | disclosed |
| US-20230219995-A1 | FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION | STEALTH LABELS BIOTECH AB (SE) | 2023-07-13 | — | — | US | disclosed |
| EP-4172170-A1 | FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION | STEALTH LABELS BIOTECH AB (SE) | 2023-05-03 | — | — | EP | disclosed |
| EP-3196191-B1 | 2-ALKYLOXY BENZENE FORMYL ARYLAMINE COMPOUND AND PHARMACEUTICAL USE THEREOF | UNIV FUDAN (CN) | 2023-04-19 | — | — | EP | disclosed |
| US-20020119955-A1 | Modified prodrug forms of AP/AMP | NANOTHERAPEUTICS, INC. | 2002-08-29 | — | — | US | disclosed |
| EP-1210055-A1 | TWO-CONSTITUENT ELASTOMER MATERIALS BASED ON ALKYL AZIRIDINE COMPRISING A CATALYST CONSTITUENT THAT CONTAINS A BORIC ACID COMPLEX | 3M Espe AG (DE) | 2002-06-05 | — | — | EP | disclosed |
| WO-2002030424-A1 | MODIFIED PRODRUG FORMS OF AP/AMP | VION PHARMACEUTICALS, INC. (US) | 2002-04-18 | — | — | WO | disclosed |
| WO-2001017483-A1 | TWO-CONSTITUENT ELASTOMER MATERIALS BASED ON ALKYL AZIRIDINE COMPRISING A CATALYST CONSTITUENT THAT CONTAINS A BORIC ACID COMPLEX | 3M ESPE AG (DE) | 2001-03-15 | — | — | WO | disclosed |
| US-5587392-A | THERAPY FOR ESTROGEN DEPENDENT DISEASES | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1996-12-24 | — | — | US | disclosed |
| EP-0684235-A1 | Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1995-11-29 | — | — | EP | disclosed |
| CN-87100524-A | Method for preserving wood | — | 1987-09-02 | — | — | CN | disclosed |
| US-4070318-A | VINYL PYRIDINE COPOLYMER RUBBER, CONDENSATION | THE GENERAL TIRE & RUBBER COMPANY (US) | 1978-01-24 | — | — | US | disclosed |
| US-4025553-A | Production of o-hydroxybenzyl alcohols | SHIONOGI & CO., LTD. (JA) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119955-A1 | Modified prodrug forms of AP/AMP | AP3B1, AP3D1, AP3M1 | HIF1A 2058/4885HPGD 2532/4885ALOX15 3863/4885 |
| US-20230219995-A1 | FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION | RNGTT, CPSF1, NSUN2 | HIF1A 3005/4885HPGD 3279/4885ALOX15 3150/4885 |
| US-11708364-B2 | Azaindole derivatives and their use as ERK kinase inhibitors | MAPKAPK2, MAPK1, MAPK3 | HIF1A 4331/4885HPGD 653/4885ALOX15 3713/4885 |
| US-20240209016-A1 | FLUORESCENT NUCLEOSIDE PHOSPHATES | RNGTT, PNP, RNMT | HIF1A 3249/4885HPGD 3543/4885ALOX15 3047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.